Publications by authors named "Phil Kalina"
Background: Malignant peritoneal mesothelioma (MPM) is a rare disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Estimation of personalized survival times can potentially guide treatment and surveillance.
Methods: We analyzed 104 patients who underwent CRS and cisplatin-based HIPEC for MPM.